Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07478146

Brief Title: Aerobic Training on Cerebrovascular Function, Cognition and Gait in Parkinson's Disease

Effects of Aerobic Training on Cerebrovascular Function, Cognitive Performance and Gait Parameters in Patients With Parkinson's Disease: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Raphael Mendes Ritti Dias · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

This randomized controlled trial will investigate the effects of a 12-week supervised aerobic training program on cerebrovascular function, peripheral vascular health, cardiovascular autonomic modulation, cognition, non-motor symptoms, sleep, mood, gait biomechanics, quality of life, and body composition in patients with Parkinson's disease (Hoehn \& Yahr stages 1-3). Participants will be randomly allocated to aerobic training or usual care.

Detailed description

This is a parallel-group randomized controlled trial Participants (n=40) diagnosed with Parkinson's disease, stages 1-3 on Hoehn \& Yahr scale, will be randomly allocated (1:1 block randomization) to: * Aerobic Training Group; * Control Group (usual care) The intervention will last 12 weeks, 3 sessions/week Pre and post-intervention assessments will include: * Cerebrovascular function: neurovascular coupling, cerebrovascular reactivity (breath-holding index), dynamic cerebral autoregulation (transfer function analysis), and acute cerebral blood flow response to exercise (transcranial Doppler; vertebral artery flow during silent reading). * Peripheral vascular and cardiovascular function: brachial artery flow-mediated dilation, carotid intima-media thickness, resting blood pressure, resting heart rate, cardiorespiratory fitness (VO₂peak), heart rate variability (time and frequency domains), and baroreflex sensitivity. * Cognitive performance: Montreal Cognitive Assessment (MoCA), Trail Making Test A and B, and Stroop Color-Word Test. * Gait biomechanics: spatiotemporal parameters, 3D kinematics (Vicon system), and kinetics (force platform). * Clinical and non-motor symptoms: UPDRS, Non-Motor Symptoms Scale (NMSS), sleep quality (PDSS), anxiety (PAS), depressive symptoms (GDS-15), apathy (Apathy Inventory), fatigue (Parkinson Fatigue Scale), pain (Numeric Rating Scale), and quality of life (PDQ-8). * Body composition: quadriceps muscle thickness and subcutaneous adipose tissue thickness assessed by ultrasound. All experimental sessions will be performed in the "on" medication state

Conditions

Interventions

TypeNameDescription
BEHAVIORALAerobic trainingAerobic Exercise Training
BEHAVIORALUsual CareUsual Care

Timeline

Start date
2026-02-28
Primary completion
2027-06-30
Completion
2027-12-31
First posted
2026-03-17
Last updated
2026-04-13

Locations

1 site across 1 country: Brazil

Source: ClinicalTrials.gov record NCT07478146. Inclusion in this directory is not an endorsement.